PCSK-9 inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PCSK-9 inhibitor, covering 2024-05-22 to 2025-11-04. Get the full timeline:
Most recent: Clinical Trial Update: The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk [Phase 4]